Meta-analysis of incidence of rare events
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
This is a review of methods for the meta-analysis of incidence of rare events using summary-level data. It is motivated and illustrated by the dataset used in a published analysis of cardiovascular safety in rosiglitazone trials. This review compares available methods for binary data, considering risk-difference, relative-risk and odds-ratio scales, fixed-effect and random-effects models, and frequentist and Bayesian approaches. Particular issues in this dataset include low incidence rates, the occurrence of studies with no events under one or all treatments, and discrepancy among results achieved using different statistical methodologies. The common method of adding a correction factor to handle zeroes may introduce bias where the incidence of events is small, as in this case. Alternative analyses on the log-odds scale are shown to give similar results, but the choice between them is less important than the potential sources of bias in any meta-analysis arising from limitations in the underlying dataset. It is important to present results carefully, including numerical and graphical summaries on the natural scale of risk when the analysis is on a statistically appropriate scale such as log-odds: the incidence rates should accompany an estimated ratio (of odds or risk) to put the analysis into the proper context. Beyond the statistical methodologies which are the focus of this paper, this dataset highlights the importance of understanding the limitations of the data being combined. Because the rosiglitazone dataset contains clinically heterogeneous trials with low event rates that were not designed or intended to assess cardiovascular outcomes, the findings of any meta-analysis of such trials should be considered hypothesis-generating.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734 · cited 3×
“This is generally considered a reasonable method for analysing rare events when the treatment effect is not large.(13) It has been reported as behaving poorly when randomisation ratios are far from 1, i.”
BackgroundMethodInfluentialMuch ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938 · cited 1×
“8:1 or greater.(14,15) In this set, there were three trials with a 4 : 1 ratio, and three with 3 : 1; in addition, one of the two very large and long trials (ADOPT, containing 43% of the events) had a 1 : 2 ratio.”
BackgroundMeta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
On simpson's paradox and the sure-thing principle
Blyth, C. R. (1972) · Journal of the American Statistical Association · doi:10.2307/2284382 · Cited by 630
Meta-analysis of rare and adverse event data
Sutton, A. J., Cooper, N. J., Lambert, P. C., Jones, D. R., Abrams, K. R., & Sweeting, M. J. (2002) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2.4.367 · Cited by 141
Shuster, J. J., Jones, L. S., & Salmon, D. A. (2007) · Statistics in Medicine · doi:10.1002/sim.3060 · Cited by 105 · cited 2×
“Shuster et al.(9) proposed a randomeffects approach that effectively treats each trial as having equal weight, and show very different results compared to the fixed-effects estimates for both MI (1.”
ResultInfluential
Cited by
Leblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., Mouzat, K., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004580 · Cited by 630
“If any contingency tables contained zero values, a continuity correction was applied to the relevant tables [57].”
MethodMeta-analysis: pitfalls and hints.
(2013) · Europe PMC (PubMed Central) · Cited by 298
Practical guide to the meta-analysis of rare events
Efthimiou, O. (2018) · Evidence Based Mental Health · doi:10.1136/eb-2018-102911 · Cited by 231
Strategies to prevent death by suicide: Meta-analysis of randomised controlled trials
Riblet, N. B. V., Shiner, B., Young-Xu, Y., & Watts, B. V. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187799 · Cited by 137
“21 More commonly used meta-analysis methods (e.g. 23 We did not apply a continuity correction for trials with zero events because this is not recommended with the Peto method.”
Braun, C., Bschor, T., Franklin, J., & Baethge, C. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442293 · Cited by 103
Metadata
- Authors
- Lane, P. W.
- Venue
- Statistical Methods in Medical Research
- Publisher
- SAGE Publications
- Published
- 2012-01-04
- Volume
- 22
- Issue
- 2
- Pages
- 117-132
- ISSN
- 0962-2802 (ISSN-L)
- 1477-0334
- OpenAlex
- W2052478986
- Cited by
- 97
- References
- 9
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis of incidence of rare events. https://app.cochat.ai/papers/10.1177/0962280211432218
- The paper
- Lane, P. W. (2013). Meta-analysis of incidence of rare events. Statistical Methods in Medical Research. https://doi.org/10.1177/0962280211432218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.